Winrevair, when added to standard of care, reduced clinical worsening events by 76% in adults recently diagnosed with PAH, trial data show.

Gossamer Bio has begun the process of acquiring Respira Therapeutics and its lead on-demand PH treatment candidate, RT234.

Stem cell-derived conditioned medium, the liquid that remains after cells are cultured, reduced PAH signs in rats and cells, ...

Tenax said the European Patent Office will grant it a patent protecting the use of levosimendan to treat PH-HFpEF in Europe.

Columnist Jolie Lizana attended the Pulmonary Hypertension Association's (PHA) PHPN Symposium, which discussed PH research.

Underweight infants with PH have a high risk of developing retinopathy of prematurity, a leading cause of childhood blindness ...

Higher pulmonary arterial pressure in pregnant women with PH was linked to longer hospitalizations, and ICU admission, in a ...

As a PH patient and transplant recipient, columnist Anna Jeter relies on her care team when it comes to vaccine recommendations.

Allrock raised $50 million to support the launch of a Phase 2a clinical trial testing PH treatment ROC-101 in people with PAH and PH-ILD.

Pulmonary hypertension (PH) is a rare but life-threatening lung disorder that damages the vessels responsible for transporting blood from the heart to the lungs, known as the pulmonary arteries. The ...